Cancer Diary: Preventing Breast Cancer at a Cost - Life after “Angelina Jolie” Surgery
When Angelina Jolie shared that she carries a BRCA1 mutation and chose a preventive double mastectomy, she did more than tell her story—she shifted the behavior of thousands of women worldwide. Rates of risk‑reducing mastectomy rose sharply after her announcement, especially among women with BRCA1 or BRCA2 mutations, who can face a lifetime breast cancer risk of 60–70% or more. The “Angelina Jolie effect” is real: more women are getting tested, more are offered options, and more are choosing aggressive surgery to lower their risk. For many, that surgery does exactly what it promises: it dramatically reduces the chance of developing breast cancer. Studies show that bilateral risk‑reducing mastectomy in BRCA1/2 carriers can cut breast cancer incidence by about 90% or more. For some women, that reduction in risk feels like the difference between living under a constant shadow and finally being able to exhale. But there’s another part of the story that doesn’t fit neatly into he...